PERK eIF2alpha kinase regulates neonatal growth by controlling the expression of circulating insulin-like growth

Yulin Li1, Kaori Iida, Jeff O'Neil

  • 1Department of Biology, The Pennsylvania State University, University Park, Pennsylvania 16802, USA.

Endocrinology
|July 17, 2003
PubMed

Insights

PERK deficiency causes severe growth retardation in neonatal mice by reducing liver IGF-I. This highlights PERK

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Developmental Biology

Background:

  • Wolcott-Rallison syndrome and PERK deficiency lead to severe postnatal growth retardation.
  • Perk-/- mice exhibit proportional dwarfism and reduced chondrocyte proliferation in growth plates.

Purpose of the Study:

  • Investigate the role of PERK in neonatal growth.
  • Determine the mechanism linking PERK deficiency to growth retardation.

Main Methods:

  • Analysis of growth parameters in Perk-/- mice.
  • Measurement of IGF-I mRNA and serum levels.
  • Assessment of growth hormone (GH) and IGF-I effects on growth retardation.
  • Transgenic rescue of PERK activity in beta-cells.

Main Results:

  • Perk-/- mice showed a 75% reduction in neonatal liver IGF-I mRNA and serum IGF-I.
  • IGF-I injections partially reversed growth retardation; GH had no effect.
  • PERK activity in beta-cells rescued juvenile but not neonatal growth.
  • Neonatal liver IGF-I is GH-independent.

Conclusions:

  • PERK regulates hepatic IGF-I expression during the GH-independent neonatal period.
  • PERK deficiency causes severe neonatal growth retardation due to impaired IGF-I regulation.
  • PERK is crucial for normal neonatal growth independent of GH signaling.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...